News | October 09, 2024
Jubilant Ingrevia becomes only Indian company to join WEF’s Global Lighthouse Network
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
The company plans to advance Ropanicant into double-blind, placebo-controlled Phase-2b clinical study in MDD patients, anticipated to start in early 2025
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
The product is expected to be launched in Q3FY25
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
Developed in consultation with clinicians and patients for an enhanced user experience
India has taken the lead in recognising NAFLD as a major non-communicable disease
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
Subscribe To Our Newsletter & Stay Updated
